ARKG

ARK Genomic Revolution Multi-Sector ETF

Down$31.40
$-0.31
(-0.98%)
As of 12:59:00 PM EDT | 11/18/19  |  Market Open

ARKG Trading Data

Open

$31.74

Low Price

$31.15

High Price

$31.74

Previous Last Price

$31.71

Bid Size

$31.38 X 600

Ask Size

$31.44 X 800

ARKG Portfolio Data

AUM

$416,895,500

Shares

13,405

PE Ratio

0

Price / Book Ratio

4.72

Expense Ratio

0.75

Net Asset Value

$31.10

Volume

Volume

28,203

Avg. Volume (YDT)

130,104

Dollar Volume

$747,060

Weekly Avg. Volume

79,975

Monthly Avg. Volume

99,214

Quarterly Avg. Volume

93,567

ARKG Fund Description

The ARK Genomic Revolution Multi-Sector ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

ARKG Chart

ARKG Summary

Fund Family

Ark Funds

Tracks This Index

ARK Genomic Revolution Multi-Sector ETF

Inception Date

2014-11-04

Asset Class

Portfolio-Multi Asset

Asset Class Size

Biotech

ARKG Classification

Region (General)

Global

Region (Specific)

Sector

Multi-Sector

Equity Index

Leveraged Family

ARKG Holdings

Top 10 Holdings

ILLUMINA INC (ILMN)
10.08%
CRISPR THERAPEUTICS AG (CRSP)
9.45%
INVITAE CORP (NVTA)
8.77%
INTELLIA THERAPEUTICS INC (NTLA)
5.94%
EDITAS MEDICINE INC (EDIT)
4.92%
TELADOC HEALTH INC (TDOC)
4.74%
IOVANCE BIOTHERAPEUTICS INC (IOVA)
4.06%
COMPUGEN LTD (CGEN)
4.05%
CELLECTIS - ADR (CLLS)
3.59%
VERACYTE INC (VCYT)
3.38%

Total ARKG Holdings

Total Holdings: 36

ILLUMINA INC (ILMN)
10.08%
CRISPR THERAPEUTICS AG (CRSP)
9.45%
INVITAE CORP (NVTA)
8.77%
INTELLIA THERAPEUTICS INC (NTLA)
5.94%
EDITAS MEDICINE INC (EDIT)
4.92%
TELADOC HEALTH INC (TDOC)
4.74%
IOVANCE BIOTHERAPEUTICS INC (IOVA)
4.06%
COMPUGEN LTD (CGEN)
4.05%
CELLECTIS - ADR (CLLS)
3.59%
VERACYTE INC (VCYT)
3.38%
NANOSTRING TECHNOLOGIES INC (NSTG)
2.98%
IONIS PHARMACEUTICALS INC (IONS)
2.96%
ARCTURUS THERAPEUTICS HOLDIN (ARCT UQ)
2.68%
GUARDANT HEALTH INC (GH)
2.63%
INCYTE CORP (INCY)
2.53%
INOVIO PHARMACEUTICALS INC (INO)
2.33%
CAREDX INC (CDNA)
2.22%
CODEXIS INC (CDXS)
2.2%
REGENERON PHARMACEUTICALS (REGN)
2.15%
CERUS CORP (CERS)
1.86%
SYROS PHARMACEUTICALS INC (SYRS)
1.77%
TWIST BIOSCIENCE CORP (TWST)
1.67%
CELLULAR BIOMEDICINE GROUP I (CBMG)
1.62%
SERES THERAPEUTICS INC (MCRB)
1.55%
FATE THERAPEUTICS INC (FATE)
1.37%
PERSONALIS INC (PSNL)
1.32%
CASTLE BIOSCIENCES INC (CSTL)
1.28%
PACIFIC BIOSCIENCES OF CALIF (PACB)
1.21%
APPLE INC (AAPL)
1.09%
BRISTOL-MYERS SQUIBB CO (BMY)
0.92%
RUBIUS THERAPEUTICS INC (RUBY)
0.81%
ORGANOVO HOLDINGS INC (ONVO)
0.55%
PLURISTEM THERAPEUTICS INC (PSTI)
0.41%
INTREXON CORP (XON)
0.4%
AQUABOUNTY TECHNOLOGIES (AQB)
0.19%
ARK Genomic Revolution Multi-Sector ETF (ARKG)
0%

ARKG Technicals

Alpha

1

Beta

1.93

Leverage

Long

Standard Deviation

2.58

ARKG Dividends

Dividend Date

2018-12-27

Latest Dividend

0.27

Annual Dividend

0.27

Annual Dividend Rate

0.27

Annual Dividend Yield

0.87

ARKG Performance

YTD Return

30.44%

1 Year Return

7.35%

3 Year Return

69.75%

5 Year Return

58.31%

10 Year Return

57.76%

ARKG Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.